Пользователь:
АНОНИМ
|
|
|
Изделия
Компании
Прайсы
Спрос
Мероприятия
Пресса
Новости
Объявления
Госзакупки
Специалисты
Поиск на сайтах
Исследования
Рубрикатор ::
Медицина/ Фармакология :: Медицинские услуги - общее ::
RUSSIAN PHARMACEUTICAL MARKET 2012
Телефон для консультаций: +7(985)920-61-98 (телефон офиса в Москве), 8(800)55-189-55 (бесплатный телефон по РФ) Вы можете заказать данный отчёт в режиме on-line прямо сейчас, заполнив небольшую форму регистрации. Заказ отчёта не обязывает к его покупке. После получения заказа на отчёт с Вами свяжется наш менеджер, который:
Поля, отмеченные звёздочкой, обязательны для заполнения. Полное описание отчёта In 2012, the audit of government programs that affect the pharmaceutical market took place. In the previous year, a number of laws were approved. It will affect the development of the market in the short and long term (for example, increasing the availability of high-quality, effective and safe medicines to meet needs of the population is the main goal of "The Strategy of providing the population of the Russian Federation with drugs till 2025". The Russian pharmaceutical market is among the ten largest pharmaceutical markets in the world. At the end of 2012 Russia took the 7th place. In Russia in 2012, the value of the pharmaceutical market amounted to 921 billion rubles (VAT) in consumer prices, which is 12% more compared to 2011. Russia was ranked third for growth rate. The Russian pharmaceutical market is import oriented. 76% of drugs in terms of money consumed by the population are produced abroad. Therefore, on the first place in the ranking of foreign producers is: SANOFI, NOVARTIS. On the third line is PHARMSTANDARD - the only domestic manufacture of the top 20 leading players in the Russian pharmaceutical market. The development of the pharmaceutical distribution sector of the market is on a given vector in recent years - business diversification: all national distributors are within the control structure of a subordinate pharmacy chains, the second direction, which is actively developing – is domestic manufacture. In 2012, there was a redistribution of the market. "Protek" took the leading position with a share of 16.5%. "Sensation" of the year – the distributor "Katren" got the second place. Rounding up the Top-3 was the distributor "SIA" (Leader of previous years). Their combined share of the total market is 44%. For the pharmacy chain, the year was marked by the development of new formats within the chain. Many market players have discount stores under different brand names now. On the other hand pharmacy chains offer premium pharmacies, shops and cosmetic studios, etc. Also redistribution of the market take place in the retail segment - the leader of the pharmacy chain is "Rigla", "A5" takes the second Подробное оглавление/содержание отчёта Summary 1. Pharmaceutical market value in Russia 3 2. Commercial segment of RTU drugs 5 3. Drug reimbursement program 11 4. Sales value in the segment of health care institutions 33 5. Nutritional supplements 50 6. Beauty products 61 7. Drug Import 71 8. Pharmacy networks 86 9. Distribution segment of the pharmaceutical market 91 10. Manufacturing Перечень приложений
Исследования по теме
Возник вопрос по содержанию отчёта? Задайте его! Персональный менеджер свяжется с Вами и поможет решить любую задачу.
Актуальные исследования и бизнес-планы
|
||||||||||||||||||||||||||||||||||||||||
|
Поиск организаций Поиск изделий | ||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||
Обмен ссылками |
|